← Human Trials & Peer-Reviewed Studies

Targeting mailed nicotine patch distribution interventions to rural regions of Canada: protocol for a randomized controlled trial

Plain-language guide to PMID 33228625 (2020): randomized clinical study of Therapeutic nicotine (patch, non-peptide).

Key Facts

PMID
33228625
Journal
BMC public health
Year
2020
Study type
Clinical Study
Authors
Cunningham JA et al. (5 authors)
DOI
10.1186/s12889-020-09810-2

What This Study Did, in Plain Language

What Was Tested

The paper reports a study of Therapeutic nicotine (patch, non-peptide), published as a clinical study.

One way of helping people stop smoking is to provide them with free Nicotine Replacement Therapy (NRT), such as when NRT is sent to people by postal mail as part of a mass distribution initiative.

The current research seeks to confirm this finding and to understand the social determinants of health driving these anticipated large effects.

Who Took Part

PubMed indexes the participants as adults.

Telephone numbers will be randomly selected from across rural regions of Canada in order to recruit adult smokers interested in completing a smoking survey and willing to be interviewed again in 6 months.

The survey will ask participants about their smoking history, demographic characteristics, and a hypothetical question: would they be interested in receiving nicotine patches if they were provided to them free of charge?

How the Study Was Run

The design is described as randomized.

Because people in this Therapeutic nicotine (patch, non-peptide) study were split into groups at random, differences between the groups are less likely to reflect who happened to join each one.

Half of the smokers interested in receiving nicotine patches will be selected by chance and offered the NRT package.

The other half of smokers will not be offered the nicotine patches.

In addition, the municipality where each participant lives will be identified and, once the relevant general population data becomes available, attempts will be made to link participant data to relevant municipal characteristics (e.g., smoking rates, availability of health services).

Characteristics of the participants and the municipalities in which they live will be used to explain why the nicotine patch intervention may have a larger impact in some rural regions compared to others.

What Was Measured

Topics PubMed links to this paper include Canada, Postal Service, Rural Population, Smoking Cessation, Tobacco Smoking, Tobacco Use Cessation Devices and Randomized Controlled Trials as Topic.

The authors tagged it with the keywords Mass distribution, NRT, Nicotine patches and Tobacco cessation.

What This Means in Plain Language

The paper is a randomized study of Therapeutic nicotine (patch, non-peptide).

Results are reported in around 2 sentences of the abstract; we leave them to the paper itself rather than summarise them.

The publication is from 2020 (BMC public health), a journal based in England.

More context: the Therapeutic nicotine (patch, non-peptide) compound page, all human trials.

Our Notes on the Compound

Therapeutic nicotine (patch, non-peptide): Pure nicotine as a signaling tool, separated from smoking and vaping.

Related Pages

Source: PubMed record. This explanation is written by PeptideWhiz from the public record. For research and education only. Not medical advice; no dosing information is given.